BR9809435A - Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc - Google Patents

Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc

Info

Publication number
BR9809435A
BR9809435A BR9809435-1A BR9809435A BR9809435A BR 9809435 A BR9809435 A BR 9809435A BR 9809435 A BR9809435 A BR 9809435A BR 9809435 A BR9809435 A BR 9809435A
Authority
BR
Brazil
Prior art keywords
diol
useful
pharmaceutically acceptable
sulfate
pregnan
Prior art date
Application number
BR9809435-1A
Other languages
English (en)
Inventor
Reinhold Hans Wilhelm Bender
Mahdi Bakir Fawzi
Horace Fletcher Iii
George Oscar Morton
Syed Muzafar Shah
Xuejun Tang
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9809435A publication Critical patent/BR9809435A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção:<B>"SAIS FARMACEUTICAMENTE ACEITáVEIS DE 3-SULFATO DE 5ALFA-PREGNAN-3BETA, 16ALFA-DIOL-20-ONA úTEIS COMO PROGESTINAS E DISTúRBIOS DO SNC"<D>. A invenção fornece um sal farmaceuticamente aceitável do éster3-sulfato de 5<244>-pregan-3<225> 16<244>-diol-20-ona, que é útil como um agente progestacional.
BR9809435-1A 1997-05-02 1998-04-28 Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc BR9809435A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85057197A 1997-05-02 1997-05-02
PCT/US1998/008454 WO1998050411A1 (en) 1997-05-02 1998-04-28 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders

Publications (1)

Publication Number Publication Date
BR9809435A true BR9809435A (pt) 2000-06-13

Family

ID=25308520

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809435-1A BR9809435A (pt) 1997-05-02 1998-04-28 Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc

Country Status (10)

Country Link
EP (1) EP0981538A1 (pt)
JP (1) JP2001527552A (pt)
KR (1) KR20010012180A (pt)
CN (1) CN1254342A (pt)
AR (1) AR012637A1 (pt)
AU (1) AU746326B2 (pt)
BR (1) BR9809435A (pt)
CA (1) CA2289096A1 (pt)
WO (1) WO1998050411A1 (pt)
ZA (1) ZA983706B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104423D0 (sv) * 2001-12-27 2001-12-27 Umecrine Ab Pregnane steroids and their use in the treatment of CNS disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895103A (en) * 1971-11-22 1975-07-15 Alza Corp Intrauterine contraceptive device containing certain pharmaceutically acceptable steroids

Also Published As

Publication number Publication date
AU746326B2 (en) 2002-04-18
KR20010012180A (ko) 2001-02-15
AU7164598A (en) 1998-11-27
EP0981538A1 (en) 2000-03-01
AR012637A1 (es) 2000-11-08
JP2001527552A (ja) 2001-12-25
CN1254342A (zh) 2000-05-24
WO1998050411A1 (en) 1998-11-12
CA2289096A1 (en) 1998-11-12
ZA983706B (en) 1999-11-01

Similar Documents

Publication Publication Date Title
BR9902086A (pt) Formulações farmacêuticas.
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
BR9914251A (pt) Formulações orais de liberação sustentada
GT199800126A (es) Terapia de combinacion.
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
BR9712491A (pt) Composições cosméticas
BR9811094A (pt) Agente terapêutico para tumores linfáticos
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer&#39;s disease and dementias
BR9813817A (pt) Análogos de hemiasterlina
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
BR9804027A (pt) Novos beta-ceto ésteres
GR3035167T3 (en) Toothbrush
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
BR9903257A (pt) Concentrado de suspensão aquosa contendo tiadiazurona e etefona
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
BR9812085A (pt) &#34;método para a sìntese de derivados de quinolina&#34;
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer&#39;s disease.
BR9812982A (pt) Agente anti-reumático
BR9809435A (pt) Sais farmaceuticamente aceitáveis de 3-sulfato de 5alfa-pregnan-3beta, 16alfa-diol-20-ona úteis como progestinas e distúrbios do snc
GEP20043286B (en) Dual Inhibitors of Cholesteryl Ester and Wax Ester Synthesis for Sebaceous Gland Disorders
ZA852495B (en) Anticonvulsant agents
DK412286A (da) 4-acylaminobenzamid-derivater, fremgangsmaade til fremstilling heraf samt mellemprodukter til brug ved fremgangsmaaden
BR9809375A (pt) Sais de éster de 3-sulfato 5-alfa-pregn-16-3beta-ol-20-ona com atividade progestina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1892 DE 10/04/2007.